|
Volumn 156, Issue 2, 2002, Pages 227-232
|
Bone abnormalities in latent TGF-β binding protein (Ltbp)-3-null mice indicate a role for Ltbp-3 in modulating TGF-β bioavailability
|
Author keywords
Latent TGF binding protein; Osteoarthritis; Osteosclerosis; Synchondroses; TGF
|
Indexed keywords
BINDING PROTEIN;
TRANSFORMING GROWTH FACTOR BETA;
TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN 3;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
BIOAVAILABILITY;
BONE DEFECT;
CONTROLLED STUDY;
CRANIOFACIAL MALFORMATION;
GENE ACTIVITY;
GENE CONTROL;
GENE FUNCTION;
GENE MUTATION;
GENE TARGETING;
HOMOZYGOTE;
KYPHOSIS;
MANDIBLE;
MAXILLA;
MOUSE;
NONHUMAN;
NULL ALLELE;
OSSIFICATION;
OSTEOARTHRITIS;
OSTEOSCLEROSIS;
PRIORITY JOURNAL;
PROTEIN PROTEIN INTERACTION;
SIGNAL TRANSDUCTION;
ADAPTOR PROTEINS, SIGNAL TRANSDUCING;
ANIMALS;
BONE AND BONES;
BONE REMODELING;
CARRIER PROTEINS;
CRANIOFACIAL ABNORMALITIES;
GENE DELETION;
GENE TARGETING;
IN SITU HYBRIDIZATION;
LATENT TGF-BETA BINDING PROTEINS;
MICE;
MICE, KNOCKOUT;
OSTEOARTHRITIS;
OSTEOSCLEROSIS;
RNA, MESSENGER;
SKULL;
TRANSFORMING GROWTH FACTOR BETA;
ANIMALIA;
|
EID: 0037148521
PISSN: 00219525
EISSN: None
Source Type: Journal
DOI: 10.1083/jcb.200111080 Document Type: Article |
Times cited : (131)
|
References (31)
|